Mepolizumab improves small airway function in severe eosinophilic asthma

L. Seccombe (Sydney, Australia), P. Rogers (Sydney, Australia), N. Reed (Sydney, Australia), T. Badal (Sydney, Australia), C. Thamrin (Sydney, Australia), G. King (Sydney, Australia), M. Peters (Sydney, Australia), C. Farah (Sydney, Australia)

Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Session: The value of lung function testing in various pathophysiological conditions
Session type: Thematic Poster
Number: 2434
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Seccombe (Sydney, Australia), P. Rogers (Sydney, Australia), N. Reed (Sydney, Australia), T. Badal (Sydney, Australia), C. Thamrin (Sydney, Australia), G. King (Sydney, Australia), M. Peters (Sydney, Australia), C. Farah (Sydney, Australia). Mepolizumab improves small airway function in severe eosinophilic asthma. 2434

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Improved small airway function by benralizumab in patients with severe eosinophilic asthma
Source: Virtual Congress 2020 – From respiratory physiology to clinical practice: exercise and respiratory muscles
Year: 2020


Mepolizumab improves activity limitation in severe eosinophilic asthma
Source: International Congress 2017 – Notable abstracts in asthma
Year: 2017



Effects of formoterol-budesonide combination on residual eosinophilic inflammation in distal airway of patients with well-controlled moderate asthma
Source: Annual Congress 2011 - Asthma management and response
Year: 2011

Parameters associated with persistent airflow obstruction in chronic severe asthma
Source: Eur Respir J 2004; 24: 122-128
Year: 2004



Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017

Cinical assessment of asthma severity partially corresponds to eosinophilic airway inflammation
Source: Eur Respir J 2002; 20: Suppl. 38, 508s
Year: 2002

Role of neutrophils in airway inflammation in children with severe persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Small airway impairment in severe asthmatic patients
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Year: 2018

Bronchiectasis and airway eosinophilia in severe asthma—is there an association?
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020


Small airways involvement is associated with bronchial hyperresponsiveness in asthma
Source: Annual Congress 2012 - Different ways to phenotype asthma
Year: 2012


Eosinophilic airway inflammation in COPD and asthma
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008


Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019

Heterogeneous response of airway eosinophilia to biologics in severe asthma patients
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021


Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017


Factors driving airway eosinophilia in prednisone-dependent severe asthma
Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma
Year: 2017


Upper airway symptoms associate with the eosinophilic phenotype of COPD
Source: ERJ Open Res, 7 (3) 00184-2021; 10.1183/23120541.00184-2021
Year: 2021



Influence of large and small dose of fluticasone propionate on clinical symptoms of bronchial asthma, lung function, bronchial hyperreactivity and eosinophilia in induced sputum
Source: Eur Respir J 2002; 20: Suppl. 38, 111s
Year: 2002

Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction
Source: Eur Respir J 2002; 20: Suppl. 38, 505s
Year: 2002

Airway remodelling is present in children with asthma regardless of eosinophilic inflammation
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009